![Caroline Dorsa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Dorsa
Direktor/Vorstandsmitglied bei
ILLUMINA, INC.
Vermögen: 10 Mio $ am 31.05.2026
Profil
Caroline D.
Dorsa is the founder of the Institute For Advanced Clinical Trials For Children, founded in 2016, serving as Director Emeritus since its founding.
Current jobs include Independent Director at Duke Energy Corp.
since 2021, Independent Director at Illumina, Inc. since 2017, Member-Supervisory Board at Biogen GmbH since 2010, and Independent Trustee at Goldman Sachs Credit Income Fund since 2019.
Former jobs include Chairman at Biogen, Inc. from 2023 to 2026; Chief Financial Officer, Director & Executive Vice President at PSEG Power LLC from 2014 to 2015; Director at Biogen Idec New Ventures, Inc.; Director at The Newark Museum of Art; Director at Junior Achievement of New Jersey, Inc. from 2009 to 2015; Director at Joule Unlimited Technologies, Inc.; Independent Director at Intellia Therapeutics, Inc. from 2015 to 2023; Chief Financial Officer & Senior Vice President at Gilead Sciences, Inc. from 2007 to 2008; SVP-Global Human, Health, Strategy & Integration at Merck & Co., Inc. from 2008 to 2009; Chief Financial Officer & Executive Vice President at Public Service Electric & Gas Co. from 2010 to 2015; Chief Financial Officer & Executive Vice President at Public Service Enterprise Group, Inc. from 2009 to 2015; Chief Financial Officer at PSEG Energy Holdings LLC; Chief Financial Officer & Senior Vice President at Avaya LLC in 2007; Chief Financial Officer & Executive Vice President at PSEG Services Corp.; Trustee at Goldman Sachs ETF Trust from 2016 to 2021; Trustee at Goldman Sachs Private Markets Fund 2018 (B) LLC; Trustee at Goldman Sachs Private Markets Fund 2018 LLC; Independent Trustee at Goldman Sachs Real Estate Diversified Income Fund; Trustee at Goldman Sachs MLP Income Opportunities Fund from 2016 to 2021; Independent Trustee at Goldman Sachs MLP & Energy Renaissance Fund from 2016 to 2021.
Education includes undergraduate degree from Colgate University and MBA from Columbia Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOGEN INC. 0,02 % | 21.04.2026 | 27 842 ( 0,02 % ) | 5 Mio $ | 31.05.2026 |
ILLUMINA, INC. 0,01 % | 21.05.2026 | 15 754 ( 0,01 % ) | 3 Mio $ | 31.05.2026 |
| 07.05.2026 | 12 723 ( 0 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Caroline Dorsa
| Unternehmen | Position | Beginn |
|---|---|---|
| ILLUMINA, INC. | Direktor/Vorstandsmitglied | 01.01.2017 |
| DUKE ENERGY CORPORATION | Direktor/Vorstandsmitglied | 06.05.2021 |
Institute For Advanced Clinical Trials For Children
 Institute For Advanced Clinical Trials For Children Miscellaneous Commercial ServicesCommercial Services The Institute For Advanced Clinical Trials For Children was a nonprofit organization dedicated to improving pediatric drug development by providing resources and support for efficient, effective pediatric clinical trials. The private company is based in Rockville. It collaborated with strategic partners including major children’s hospitals and universities, offered educational webinars, and published research on pediatric clinical trial methodologies and regulatory topics. The American company was founded by Caroline D. Dorsa. Alexandre P. LeBeaut has been the CEO of the company since 2021. | Gründer | 01.01.2016 |
Goldman Sachs Credit Income Fund
 Goldman Sachs Credit Income Fund Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Direktor/Vorstandsmitglied | 02.12.2019 |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2010 |
Ehemalige bekannte Positionen von Caroline Dorsa
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Vorsitzender | 09.06.2026 |
| INTELLIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.06.2023 |
| GOLDMAN SACHS MLP AND ENERGY RENAISSANCE FUND | Direktor/Vorstandsmitglied | 01.01.2021 |
Goldman Sachs ETF Trust
 Goldman Sachs ETF Trust Investment Trusts/Mutual FundsMiscellaneous Exists as exchange Traded Fund | Direktor/Vorstandsmitglied | 01.01.2021 |
| ░░░░░░░ ░░░░░ ░░░ ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Caroline Dorsa
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
27
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 27 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Public Service Electric & Gas Co.
 Public Service Electric & Gas Co. Electric UtilitiesUtilities Supplies electricity and gas | Utilities |
Public Service Enterprise Group, Inc.
 Public Service Enterprise Group, Inc. Electric UtilitiesUtilities Operates as a holding company with interest in transmission and distribution of electricity & natural gas | Utilities |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
PSEG Energy Holdings LLC
 PSEG Energy Holdings LLC Electric UtilitiesUtilities Engages in generation of electricity from solar energy | Utilities |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Avaya LLC
 Avaya LLC Packaged SoftwareTechnology Services Develops AI based enterprise CX platform | Technology Services |
PSEG Power LLC
 PSEG Power LLC Electric UtilitiesUtilities Owns and operates nuclear plants | Utilities |
PSEG Services Corp.
 PSEG Services Corp. Miscellaneous Commercial ServicesCommercial Services Provides business support services | Commercial Services |
Goldman Sachs ETF Trust
Goldman Sachs ETF Trust Investment Trusts/Mutual FundsMiscellaneous Exists as exchange Traded Fund | Miscellaneous |
Goldman Sachs MLP Income Opportunities Fund
 Goldman Sachs MLP Income Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Goldman Sachs MLP & Energy Renaissance Fund
 Goldman Sachs MLP & Energy Renaissance Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Goldman Sachs Real Estate Diversified Income Fund
 Goldman Sachs Real Estate Diversified Income Fund Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke Energy Corp.
 Duke Energy Corp. Electric UtilitiesUtilities Generates, transmits and distributes electricity & natural gas | Utilities |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
The Newark Museum of Art
 The Newark Museum of Art Other Consumer ServicesConsumer Services Operates museum | Consumer Services |
Junior Achievement of New Jersey, Inc.
 Junior Achievement of New Jersey, Inc. Part of JA Worldwide, Inc., Junior Achievement of New Jersey, Inc. is a company based in Princeton, NJ. James W. Horne has been the CEO of the company since 2022. | |
Joule Unlimited Technologies, Inc.
 Joule Unlimited Technologies, Inc. Industrial SpecialtiesProcess Industries Produces renewable fuels, gases and chemicals | Process Industries |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Goldman Sachs Private Markets Fund 2018 (B) LLC
 Goldman Sachs Private Markets Fund 2018 (B) LLC Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Goldman Sachs Private Markets Fund 2018 LLC
 Goldman Sachs Private Markets Fund 2018 LLC Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Goldman Sachs Credit Income Fund
Goldman Sachs Credit Income Fund Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Institute For Advanced Clinical Trials For Children
Institute For Advanced Clinical Trials For Children Miscellaneous Commercial ServicesCommercial Services The Institute For Advanced Clinical Trials For Children was a nonprofit organization dedicated to improving pediatric drug development by providing resources and support for efficient, effective pediatric clinical trials. The private company is based in Rockville. It collaborated with strategic partners including major children’s hospitals and universities, offered educational webinars, and published research on pediatric clinical trial methodologies and regulatory topics. The American company was founded by Caroline D. Dorsa. Alexandre P. LeBeaut has been the CEO of the company since 2021. | Commercial Services |
